Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Informed consent obtained from the subject and/or his/her legally authorised representative (LAR) before any trial-related activities~* Injury(ies) due to a blunt and or penetrating trauma~* Receipt of 6 units of PRBC within a 4 hour period following admittance to the trauma centre~* Receipt of 8 units of PRBC upon administration of trial drug~Exclusion Criteria:~* Prehospital cardiac arrest~* Cardiac arrest in the ER or OR~* Gunshot wound to the head~* Glasgow Coma Scale below 8~* Base deficit of above 15 mEq/l or severe acidosis~* Transfusion of 8 units or more of PRBC prior to arrival in trauma centre

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Activated recombinant human factor VII (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).